Cancer is in Switzerland the second leading cause of death. Among the different types of cancers, non-small cell lung cancer (NSCLC) kills the most patients and remains largely incurable. Unfortunately, even newly approved therapies can extend the life of patients only by a few months and only few survive the metastatic stadium long-term.
Discovering new cancer treatments in the “dark matter” of the human genome
October 6, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022